122 related articles for article (PubMed ID: 21933833)
1. Reduction of age-associated arterial wall changes by low-dose valsartan.
Lunder M; Janic M; Sabovic M
Eur J Prev Cardiol; 2012 Dec; 19(6):1243-9. PubMed ID: 21933833
[TBL] [Abstract][Full Text] [Related]
2. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
Lunder M; Janić M; Jug B; Sabovič M
Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
[TBL] [Abstract][Full Text] [Related]
3. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
[TBL] [Abstract][Full Text] [Related]
4. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
[TBL] [Abstract][Full Text] [Related]
5. Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot study.
Lunder M; Janić M; Habjan S; Sabovič M
Atherosclerosis; 2011 Apr; 215(2):446-51. PubMed ID: 21300350
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension.
Okura T; Watanabe S; Kurata M; Koresawa M; Irita J; Enomoto D; Jotoku M; Miyoshi K; Fukuoka T; Higaki J
Clin Exp Hypertens; 2008 Jul; 30(5):415-22. PubMed ID: 18633763
[TBL] [Abstract][Full Text] [Related]
7. Improvement of arterial wall phenotype in subjects at moderate cardiovascular risk induced by very low-dose fluvastatin/valsartan combination: a pilot study.
Turk Veselič M; Žorž N; Eržen B; Škerl P; Novaković S; Janić M; Šabovič M
Int Angiol; 2018 Oct; 37(5):356-364. PubMed ID: 29952159
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
Rehman A; Rahman AR; Rasool AH
J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
[TBL] [Abstract][Full Text] [Related]
9. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
Karalliedde J; Smith A; DeAngelis L; Mirenda V; Kandra A; Botha J; Ferber P; Viberti G
Hypertension; 2008 Jun; 51(6):1617-23. PubMed ID: 18426991
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic.
Takami T
Hypertens Res; 2009 Dec; 32(12):1086-90. PubMed ID: 19779491
[TBL] [Abstract][Full Text] [Related]
11. Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure.
Boutouyrie P; Beaussier H; Achouba A; Laurent S;
J Hypertens; 2014 Jan; 32(1):108-14. PubMed ID: 24275838
[TBL] [Abstract][Full Text] [Related]
12. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
[TBL] [Abstract][Full Text] [Related]
13. [Dilation of the brachial artery in response to sublingual nitroglycerin can predict the antihypertensive effects of valsartan: a study using novel high-frequency high-frame-rate ultrasound imaging].
Inoue M; Fujii S; Taisei M; Furumoto T; Kaga S; Komatsu H; Goto K; Komuro K; Yamada S; Onozuka H; Kitabatake A; Tsutsui H
J Cardiol; 2006 Jan; 47(1):9-14. PubMed ID: 16475468
[TBL] [Abstract][Full Text] [Related]
14. Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study.
Turk Veselič M; Eržen B; Hanžel J; Piletič Ž; Šabovič M
Med Sci Monit; 2018 Sep; 24():6892-6899. PubMed ID: 30266894
[TBL] [Abstract][Full Text] [Related]
15. Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis.
Han SH; Kang EW; Yoon SJ; Yoon HS; Lee HC; Yoo TH; Choi KH; Han DS; Kang SW
Nephrol Dial Transplant; 2011 Nov; 26(11):3722-8. PubMed ID: 21385862
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension.
Kosch M; Levers A; Lang D; Bartels V; Rahn KH; Pavenstädt H; Hausberg M
Nephrol Dial Transplant; 2008 Jul; 23(7):2280-5. PubMed ID: 18194979
[TBL] [Abstract][Full Text] [Related]
17. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
18. Predictors of candesartan's effect on vascular reactivity in patients with coronary artery disease.
Lee SR; Chae IH; Kim HL; Kang DY; Kim SH; Kim HS
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28796934
[TBL] [Abstract][Full Text] [Related]
19. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
Janić M; Lunder M; Prezelj M; Šabovič M
J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
